These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28506251)

  • 21. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
    Carrillo-Muñoz AJ; Quindós G; Gasser I; Tur-Tur C; Ruesga MT; Alonso-Vargas R; Arévalo P; Bornay-Llinares FJ; Santos P; del Valle O
    Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples.
    Nourrisson C; Moniot M; Lavergne RA; Robert E; Bonnin V; Hagen F; Grenouillet F; Cafarchia C; Butler G; Cassaing S; Sabou M; Le Pape P; Poirier P; Morio F
    Clin Microbiol Infect; 2023 Feb; 29(2):257.e7-257.e11. PubMed ID: 36209989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.
    Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
    Dannaoui E; Paugam A; Develoux M; Chochillon C; Matheron J; Datry A; Bouges-Michel C; Bonnal C; Dromer F; Bretagne S
    Clin Microbiol Infect; 2010 Jul; 16(7):863-9. PubMed ID: 19778296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Species distribution and antifungal susceptibilities of yeast clinical isolates from three hospitals in Korea, 2001 to 2007].
    Lee MK; Yong D; Kim M; Kim MN; Lee K
    Korean J Lab Med; 2010 Aug; 30(4):364-72. PubMed ID: 20805708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
    Chen YC; Kuo SF; Chen FJ; Lee CH
    Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antifungal susceptibility of emerging yeast pathogens].
    García-Martos P; Domínguez I; Marín P; García-Agudo R; Aoufi S; Mira J
    Enferm Infecc Microbiol Clin; 2001; 19(6):249-56. PubMed ID: 11440661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method.
    Pfaller MA; Hata K; Jones RN; Messer SA; Moet GJ; Castanheira M
    Diagn Microbiol Infect Dis; 2011 Oct; 71(2):167-70. PubMed ID: 21696907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wild and partially synanthropic bird yeast diversity, in vitro virulence, and antifungal susceptibility of Candida parapsilosis and Candida tropicalis strains isolated from feces.
    Glushakova A; Kachalkin A
    Int Microbiol; 2024 Jun; 27(3):883-897. PubMed ID: 37874524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
    Godoy JS; de Souza Bonfim-Mendonça P; Nakamura SS; Yamada SS; Shinobu-Mesquita C; Pieralisi N; Fiorini A; Svidzinski TI
    J Oral Pathol Med; 2013 Mar; 42(3):229-34. PubMed ID: 22978344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
    Martinez LR; Casadevall A
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM; Reviákina V; Dolande M; Selgrad S
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
    Francisco EC; de Almeida Junior JN; de Queiroz Telles F; Aquino VR; Mendes AVA; de Andrade Barberino MGM; de Tarso O Castro P; Guimarães T; Hahn RC; Padovan ACB; Chaves GM; Colombo AL
    Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility of amphotericin-B, voriconazole and caspofungin against Candida guilliermondii biofilms, isolated from dentals units water pipes, under different growth phases.
    Mazari W; Boucherit-Otmani Z; Boucherit K
    J Mycol Med; 2015 Mar; 25(1):57-62. PubMed ID: 25533329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
    Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
    Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal susceptibility of yeasts isolated from anthropogenic watershed.
    Milanezi ACM; Witusk JPD; VAN DER Sand ST
    An Acad Bras Cienc; 2019; 91(1):e20170369. PubMed ID: 30569963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of antifungal combinations against Candida albicans biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
    J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biofilm production and antifungal susceptibility patterns of Candida species isolated from hospitalized patients].
    Demirbileki M; Timurkaynak F; Can F; Azap O; Arslan H
    Mikrobiyol Bul; 2007 Apr; 41(2):261-9. PubMed ID: 17682713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspects related to biofilm production and antifungal susceptibility of clinically relevant yeasts of the genus Trichosporon.
    Lara BR; de Camargo BB; Paula CR; Monari GPM; Garces HG; Arnoni MV; Silveira M; Gimenes VMF; Leite Junior DP; Bonfietti LX; Oliveira L; Melhem MSC; Auler M; Ramos RTB; Dias ALT; Silva NC; Moreira D; Richini-Pereira VB; Anversa L; Ruiz LDS
    Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36807459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.